NovaBay Pharma (NBY) Reports Q3 Loss of $0.08/sh
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.08), versus ($0.02) reported last year. Revenue for the quarter came in at $2.2 million, versus $1.62 million reported last year.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- XP Inc eyes US banking license as next business step
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
